A comparative study of the interaction of warfarin with human alpha 1-acid glycoprotein and human albumin.
The interaction of warfarin with human alpha 1-acid glycoprotein (alpha 1-AGP) and human albumin (HA) has been investigated using fluorescence and circular dichroism techniques. The fluorescence of warfarin is greatly enhanced following binding to alpha 1-AGP or HA, the binding constant for a single site being estimated by the Scatchard method. The binding constants for the two serum proteins are similar, but the thermodynamic parameters differ. The binding constants increase as the pH is raised to 9.0. Various basic drugs, such as chlorpromazine, propranolol and imipramine, markedly inhibited the binding of warfarin to alpha 1-AGP. But, some acidic drugs, including phenylbutazone, effectively displaced warfarin bound to HA. The difference in CD spectra observed for alpha 1-AGP and HA indicated that the drug-binding sites of the two proteins might have different asymmetries. It thus appears that the mode of interaction of warfarin with the two proteins differs.
D002942:Circular Dichroism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D009961:Orosomucoid / Q000032:analysis*; D011485:Protein Binding; D012709:Serum Albumin / Q000032:analysis*; D013050:Spectrometry, Fluorescence; D013816:Thermodynamics; D014859:Warfarin / Q000032:analysis*
D009961:Orosomucoid; D012709:Serum Albumin; D014859:Warfarin